Limitations of current therapies to prevent thrombosis: a need for novel strategies. - Wikidata - wikimedia - TriplyDB

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

http://www.wikidata.org/entity/Q37679719

about

Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?Anti-platelet therapy: ADP receptor antagonists.Hemostatic and toxinological diversities in venom of Micrurus tener tener, Micrurus fulvius fulvius and Micrurus isozonus coral snakes Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.Tetraspanin microdomains: fine-tuning platelet function.Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.Roles of affinity and lipophilicity in the slow kinetics of prostanoid receptor antagonists on isolated smooth muscle preparations.

P2860

Q28543952-93F89836-35A2-4678-A880-0DA796B83F8B Q35278165-6A35BE3D-D8A5-47E0-9264-9EEA50B1C32B Q35832488-73CA400B-99DC-4A35-B7A8-C366020DFFFB Q36459685-3FF96C1B-A2F5-47C5-9FBD-217C65F51898 Q37856391-C675E01B-A8F6-4920-9BDD-8319551786B6 Q38197732-C98B8459-48D1-4C35-934B-5AAA8277B084 Q41984226-C1E71439-7CD6-4585-B58C-C8C1DBE9C24C

P2860

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

http://www.wikidata.org/entity/Q37679719

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@en

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@nl

type

label

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@en

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@nl

prefLabel

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@en

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@nl

P1433

Q37679719-00E37914-1F7C-4FE8-9A5D-7B3FC4A8709D

P1476

Q37679719-7DBE357C-9880-4E44-A295-7496B85250E6

P2093

Q37679719-0DEA471F-31A4-418E-98E8-1AE5937C1DB2

Q37679719-B46ED6FA-A990-4F7B-939B-499C2D773D6A

P2860

Q37679719-046902C7-7C71-47F6-A2F8-7BE1177627A4

Q37679719-082C328E-C51A-4B83-9F76-8C7A400176F8

Q37679719-09F6C5E1-3A0F-4287-AE58-B2F58122A7CA

Q37679719-0B53FB56-7930-4613-9920-511308AD6BB6

Q37679719-0BBD73C7-540D-4F1F-AB3B-BDFEA81DF778

Q37679719-0E27D819-6ACE-4C9F-B99B-EC17083DB4DC

Q37679719-10A6612E-9B79-45CA-B235-3E5DC32E81D7

Q37679719-14F17A48-8A61-430E-AE12-4B3385C50D2A

Q37679719-152E41B9-FC31-4705-9EE0-D62E392D1E0F

Q37679719-154FAA7F-AE2A-459C-BA9D-2E3B9C4CE719

P304

Q37679719-26961186-5191-4BBD-8504-2C50044CCBAA

P31

Q37679719-84819B1D-AEBE-4125-8E41-36619591939C

P356

Q37679719-567619DD-CD29-45C1-BED9-E18FD64FE58B

P433

Q37679719-C6CB0D65-CD1C-469E-AABB-185FB4529188

P478

Q37679719-D335C08B-D7D8-4F3C-A26C-1B50F337BAF7

P577

Q37679719-9B88910A-232C-4E3E-BB5A-749A4A98A5DF

P698

Q37679719-A49CC532-8EFA-426B-A220-BF8F26883AD5

P921

Q37679719-768C0416-2CDB-45E6-8D8A-37BE72C7F602

P356

P1433

Molecular BioSystems

P1476

Limitations of current therapies to prevent thrombosis: a need for novel strategies.

@en

P2093

Jean-Etienne Fabre

http://www.w3.org/2001/XMLSchema#string

Mark E Gurney

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Actin dynamics in platelets

VASP protects actin filaments from gelsolin: an in vitro study with implications for platelet actin reorganizations

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

Phosphorylation of the vasodilator-stimulated phosphoprotein regulates its interaction with actin

Role of prostacyclin in the cardiovascular response to thromboxane A2

Low-dose aspirin for the prevention of atherothrombosis

Prostaglandins and leukotrienes: advances in eicosanoid biology

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Clinical practice. Acute ischemic stroke

P304

305-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/B914375K

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20094648

http://www.w3.org/2001/XMLSchema#string

P921